MOTS-c Peptide Research: Mitochondrial-Derived Signaling, AMPK Activation, and Preclinical Metabolic Evidence

MOTS-c (mitochondrial open reading frame of the 12S rRNA type-c) is a 16-amino-acid mitochondrial-derived peptide that activates AMPK by inhibiting the folate cycle, translocates to the nucleus under metabolic stress to regulate nuclear gene expression, and in mice prevents diet-induced obesity and age-dependent insulin resistance while improving physical performance. MOTS-c peptide research began with its discovery by Changhan Lee and colleagues in 2015 and now spans metabolism, exercise biology, population genetics and aging. This article summarises the published mechanism and preclinical evidence, with the primary paper cited for each finding.

The peptide matters beyond its own pharmacology. It is the clearest demonstration that mitochondria encode signalling peptides within genes long classified as non-coding, and that those peptides can act on the nuclear genome. For researchers working on metabolic peptides, exercise biology or mitochondrial signalling, MOTS-c is the reference compound for mitonuclear communication.

Discovery and Mitochondrial Origin

MOTS-c is encoded by a short open reading frame within the mitochondrial 12S rRNA gene (MT-RNR1). Its sequence is Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg, which matches the 16-residue, approximately 2174 Da specification on our MOTS-c product page. Lee and colleagues reported it after the discovery of humanin, another mitochondrial short open reading frame product, suggested that further sORFs might exist in the mitochondrial genome. They found that MOTS-c regulates insulin sensitivity and metabolic homeostasis, that its primary target organ appears to be skeletal muscle, and that its cellular action is to inhibit the folate cycle and its tethered de novo purine biosynthesis, leading to AMPK activation (Lee et al., Cell Metabolism, 2015, 21:443-454).

MOTS-c belongs to the family of mitochondrial-derived peptides that also includes humanin and the small humanin-like peptides SHLP1 to SHLP6. Because mitochondrial DNA is maternally inherited and does not recombine, MOTS-c variants track with mitochondrial haplogroups. The best-studied is m.1382A>C (rs111033358), a Northeast Asian-specific polymorphism that replaces lysine 14 with glutamine (K14Q). Its population biology is discussed in its own section below, because the direction of its association with diabetes has been reported inconsistently in secondary sources and the primary data are sex-specific.

AMPK Activation: The Central Metabolic Mechanism

The metabolic mechanism of MOTS-c runs through AMP-activated protein kinase, the cell’s energy sensor. AMPK activation increases glucose uptake and fatty acid oxidation and suppresses energy-consuming anabolic pathways. Lee and colleagues showed that MOTS-c activates AMPK indirectly: by inhibiting the folate cycle it interrupts the de novo purine synthesis that is tethered to it, which raises the level of the purine intermediate AICAR, an endogenous AMPK activator that mimics AMP binding to the kinase’s gamma subunit (Lee et al., 2015). This places MOTS-c upstream of the energy-sensing machinery rather than at the kinase itself. Fold-change figures for AICAR accumulation and AMPK Thr172 phosphorylation are reported in the paper’s figures rather than its abstract, and this article does not restate them.

The folate cycle link also touches methionine metabolism and S-adenosylmethionine, the cell’s methyl donor for epigenetic modification, which is one route by which a mitochondrial peptide could influence nuclear gene expression. A second, more direct route has since been demonstrated and is described below. A further target has been identified more recently: Kumagai and colleagues showed that MOTS-c binds casein kinase 2 (CK2) directly and activates it in cell-free systems, that MOTS-c administration to mice prevented skeletal muscle atrophy and enhanced muscle glucose uptake, that both effects were blunted by suppressing CK2, and that the effect is tissue-specific, with systemic MOTS-c stimulating CK2 in muscle while suppressing it in fat (Kumagai et al., iScience, 2024, 27:111212).

Metabolic Regulation and Glucose Homeostasis

In the discovery paper, MOTS-c treatment in mice prevented both age-dependent and high-fat-diet-induced insulin resistance, as well as diet-induced obesity (Lee et al., 2015). Lu and colleagues extended the model to ovariectomised mice, where low oestrogen drives fat accumulation and insulin resistance: MOTS-c prevented ovariectomy-induced obesity and insulin resistance, increased brown fat activation, reduced fat accumulation and inflammatory infiltration in white adipose tissue, and lowered serum and liver fatty acids, with an AMPK inhibitor attenuating the effect on adipocyte lipid metabolism (Lu et al., Journal of Molecular Medicine, 2019, 97:473-485). The same group showed that MOTS-c enhances cold tolerance and upregulates brown adipose thermogenic gene expression and white fat browning through ERK signalling (Lu et al., International Journal of Molecular Sciences, 2019, 20:2456).

Percentage improvements in glucose tolerance, HOMA-IR reductions, body weight differences in grams, fold changes in CPT1 expression and DEXA-measured visceral fat reductions have circulated in secondary accounts of these studies. None of those figures appears in the abstracts of the papers cited here, and they are not reproduced.

Nuclear Translocation and Stress-Adaptive Gene Regulation

Kim, Son, Benayoun and Lee showed that MOTS-c translocates to the nucleus and regulates nuclear gene expression following metabolic stress, in an AMPK-dependent manner. In the nucleus it regulated a broad range of genes in response to glucose restriction, including genes carrying antioxidant response elements, and it interacted with ARE-regulating stress-responsive transcription factors including NRF2 (Kim et al., Cell Metabolism, 2018, 28:516-524). The authors’ interpretation is that the mitochondrial and nuclear genomes co-evolved to encode factors that cross-regulate each other, so that mitonuclear communication is genetically integrated rather than mediated only by metabolites and reactive oxygen species.

This nuclear role adds a layer to the AMPK mechanism. During metabolic stress the peptide acts on the cytoplasmic energy sensor and on the nuclear transcriptional programme at the same time. One human caveat belongs here: D’Souza and colleagues, examining skeletal muscle from healthy men, found that muscle MOTS-c expression was not associated with ARE-related genes as it had been in culture, a reminder that cell-line findings do not automatically transfer to tissue (D’Souza et al., Aging, 2020, 12:5244-5258).

Exercise Mimetic Properties

The exercise-mimetic description rests on Reynolds and colleagues’ work. They reported that MOTS-c can significantly enhance physical performance in young (2 month), middle-aged (12 month) and old (22 month) mice; that it regulates nuclear genes related to metabolism and proteostasis, skeletal muscle metabolism and myoblast adaptation to metabolic stress; and that intermittent treatment three times a week begun late in life, at 23.5 months, increased physical capacity and healthspan. In humans, exercise induced endogenous MOTS-c expression in skeletal muscle and in the circulation (Reynolds et al., Nature Communications, 2021, 12:470). Secondary accounts sometimes attribute the aged-mouse data, with specific treadmill percentages, to a “Lee 2019 Cell Metabolism” paper; no such paper exists, and the aged-mouse and exercise findings are Reynolds 2021.

The downstream effects overlap with known exercise adaptations: AMPK activation, increased muscle glucose uptake, and, in the CK2 work above, protection against muscle atrophy. For researchers studying tissue repair peptides like BPC-157 or growth hormone secretagogues like ipamorelin, MOTS-c is a useful mechanistic contrast: where secretagogues act through a hormonal axis, MOTS-c acts on cellular energy metabolism directly.

Aging and Endogenous MOTS-c

The relationship between MOTS-c and aging is more complicated than a simple decline. In healthy aging men, D’Souza and colleagues found that circulating MOTS-c fell with age, but that older (70 to 81 years) and middle-aged (45 to 55 years) men had about 1.5-fold higher skeletal muscle MOTS-c expression than young men (18 to 30 years). Plasma and muscle levels correlated only in the young group; muscle MOTS-c was associated with markers of slow-type fibres and, in the older group, with better muscle quality measured as maximal leg-press load relative to thigh cross-sectional area (D’Souza et al., 2020). Plasma and muscle MOTS-c are therefore regulated differently with age, and the rise in muscle expression is consistent with a fast-to-slow fibre transition rather than depletion. A “20 percent per decade” plasma decline figure from a 144-person cross-sectional study, repeated in several secondary sources, could not be traced to any published paper.

Circulating MOTS-c also tracks metabolic stress rather than simply health. In 125 Chinese adults without diabetes, plasma MOTS-c and SHLP2 were elevated in those with metabolic syndrome, associated most strongly with waist circumference, and driven by android and particularly liver fat; the same rise was seen in mice on a diet that induces hepatic lipid accumulation, leading the authors to propose that liver stress is a mitochondrial peptide signal (Sequeira et al., Biochimica et Biophysica Acta General Subjects, 2021, 1865:129991). AMPK activation also connects MOTS-c to NAD+ metabolism, covered in our NAD+ and sirtuin pathway article.

Population Genetics and the K14Q Variant

The m.1382A>C polymorphism is the natural experiment in MOTS-c biology. Fuku and colleagues first suggested that this Northeast Asian-specific variant might be among the mechanisms behind Japanese longevity (Fuku et al., Aging Cell, 2015, 14:921-923). The larger and later dataset points the other way for men. Zempo and colleagues meta-analysed three cohorts totalling 27,527 people and found that males, but not females, carrying the C allele had a higher prevalence of type 2 diabetes; in the J-MICC cohort the excess was confined to men in the lowest tertile of physical activity. High-fat-fed male mice given MOTS-c lost weight and improved glucose tolerance, whereas mice given K14Q MOTS-c did not, and K14Q MOTS-c showed diminished insulin sensitisation in vitro (Zempo et al., Aging, 2021, 13:1692-1717). Kumagai’s CK2 work supplies the mechanism: K14Q MOTS-c has reduced binding to CK2 and does not activate it, and male K14Q carriers showed higher risk of sarcopenia and type 2 diabetes in an age- and activity-dependent manner, while females had an age-specific reduced risk (Kumagai et al., 2024).

The variant also shapes muscle. In 211 healthy Japanese individuals, C-allele carriers had a higher proportion of fast-twitch MHC-IIx fibres; men with the C allele had higher peak torque in leg flexion and extension; and the C allele frequency was 6.5 percent in sprint and power athletes, 5.1 percent in controls and 2.9 percent in endurance athletes (Kumagai et al., Biochimica et Biophysica Acta General Subjects, 2022, 1866:130048). Two corrections to figures that have circulated: the variant is carried by roughly one in twenty Japanese controls, not 45 percent of East Asian haplogroups, and the odds ratios previously attached to “reduced diabetes risk” and to a “2018 Aging Cell centenarian study” do not correspond to any published abstract. For researchers designing MOTS-c studies, the practical point stands: the variant present in a model system or a human cohort changes the peptide’s activity and should be documented.

Anti-Inflammatory and Cellular Stress Resistance

In mice challenged with methicillin-resistant Staphylococcus aureus, Zhai and colleagues found that MOTS-c significantly improved survival and decreased bacterial load, with lower TNF-alpha, IL-6 and IL-1beta and higher IL-10, enhanced macrophage bactericidal capacity, inhibited MAPK phosphorylation and increased AhR and STAT3 expression in macrophages (Zhai et al., Molecular Immunology, 2017, 92:151-160). In a lipopolysaccharide sepsis model, Bai and colleagues reported that MOTS-c given before the challenge increased survival, reduced inflammatory factor expression, reversed the increase in blood-brain barrier permeability and increased neurotrophic factor expression (Bai et al., International Journal of Neuroscience, 2026, 136:329-342). Specific percentage reductions in TNF-alpha and IL-6 attributed to a “2021 endotoxemia study” could not be located and are not repeated.

The endothelial evidence comes from a 2025 study rather than from the hydrogen peroxide cell-death percentages that circulate in secondary sources. Wang and colleagues identified MOTS-c as a mediator of remote ischaemic preconditioning in lung ischaemia-reperfusion injury: serum MOTS-c fell after injury in lung transplant recipients and rose when preconditioning was performed, intravenous MOTS-c in mice reproduced the protection, conditioned medium from repeatedly hypoxic human skeletal muscle cells protected endothelial cells from oxygen-glucose deprivation only when MOTS-c was present, and the protection depended on NRF2 (Wang et al., Free Radical Biology and Medicine, 2025, 229:127-138). The combined picture, AMPK for energy metabolism and NRF2 for stress defence, is what makes MOTS-c relevant to metabolic disease models in which inflammation and oxidative stress are intertwined. Its mechanism differs from TB-500, which acts through actin sequestration and cell migration, and from GHK-Cu, which acts through copper-dependent pathways.

Storage and Research Handling

For laboratory research, MOTS-c should be stored as lyophilized powder at -20 °C, protected from light and moisture. The sequence carries two methionines, at positions 1 and 6, and a tryptophan at position 3, so oxidation and photo-oxidation are the relevant chemical liabilities; minimise headspace oxygen and light. Reconstitute in bacteriostatic water at the working concentration the experiment needs, aliquot into single-use volumes and freeze once. Our reconstitution guide and degradation pathways article cover the chemistry.

Purity Verification for Mitochondrial Peptides

The 16-residue length and the tyrosine, phenylalanine and tryptophan content of MOTS-c make it well suited to reversed-phase HPLC with UV detection, and its average mass of about 2174 Da should be confirmed by mass spectrometry against the certificate. Because the two methionines oxidise readily, the impurity table should be read for sulfoxide peaks. For a comparison of the methods, see HPLC versus mass spectrometry for peptide purity verification. Maple Research Labs submits manufactured batches to an independent laboratory for HPLC purity analysis and publishes the measured result for each tested batch on the certificates of analysis page, which also lists batches still awaiting a report.

Research Summary

MOTS-c is a 16-residue peptide encoded in the mitochondrial 12S rRNA gene that activates AMPK by inhibiting the folate cycle and raising AICAR, binds and activates CK2 in muscle, and translocates to the nucleus under metabolic stress to regulate ARE-containing genes with NRF2. In mice it prevents diet-induced obesity and age-dependent insulin resistance, protects against ovariectomy-induced metabolic dysfunction, enhances physical performance at every age tested and extends healthspan when started late in life. In humans, exercise induces it in muscle and circulation, muscle expression rises with age while plasma levels fall, and the East Asian K14Q variant reduces its activity, raising type 2 diabetes prevalence in sedentary men while shifting muscle toward fast-twitch fibres.

Research Outlook

Active questions include the tissue specificity of CK2 modulation, the relationship between plasma MOTS-c and liver fat as a stress signal, the interaction between the K14Q variant and physical activity, and the interplay between MOTS-c and the other mitochondrial-derived peptides, humanin and the SHLPs. For Canadian researchers sourcing mitochondrial-derived peptides for preclinical work, batch-specific purity data matter because oxidised methionine impurities will alter AMPK activation assays. Maple Research Labs provides MOTS-c with independent third-party analysis of tested batches from a Canadian peptide supplier.

MOTS-c sits within a broader group of signalling peptides studied in metabolic models. Related mechanism reviews include humanin and mitochondrial cytoprotection, irisin and FNDC5-mediated adipose browning and cholecystokinin receptor pharmacology in vagal satiety signalling.

For research purposes only. Not for human consumption. Not for diagnostic or therapeutic use.

For peer-reviewed research on this topic, visit PubMed.